Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
11.05
+0.63 (6.05%)
At close: Jan 22, 2026, 4:00 PM EST
10.39
-0.66 (-5.97%)
After-hours: Jan 22, 2026, 7:23 PM EST
Fulcrum Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Buy
Price Target
$16.38
Upside
+48.24%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $14 → $18 | Strong Buy | Maintains | $14 → $18 | +62.90% | Dec 11, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $6 → $7 | Sell | Maintains | $6 → $7 | -36.65% | Dec 9, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $7 → $10 | Hold | Maintains | $7 → $10 | -9.50% | Dec 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $15 → $24 | Buy | Maintains | $15 → $24 | +117.19% | Dec 8, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $16 → $23 | Buy | Reiterates | $16 → $23 | +108.14% | Dec 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $25 | Strong Buy | Maintains | $18 → $25 | +126.24% | Dec 8, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +26.70% | Nov 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $18 | Strong Buy | Maintains | $12 → $18 | +62.90% | Nov 24, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $5 → $7 | Hold | Maintains | $5 → $7 | -36.65% | Oct 30, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $13 → $16 | Buy | Reiterates | $13 → $16 | +44.80% | Oct 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +8.60% | Oct 20, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $4 → $5 | Hold | Maintains | $4 → $5 | -54.75% | Jul 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $4 → $12 | Hold → Strong Buy | Upgrades | $4 → $12 | +8.60% | Jul 29, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $9 | Buy | Maintains | $6 → $9 | -18.55% | May 29, 2025 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $4 → $12 | Hold → Buy | Upgrades | $4 → $12 | +8.60% | May 23, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold → Buy Upgrades $10 | Hold → Buy | Upgrades | $10 | -9.50% | May 15, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.